Practice guidelines released for HER2 testing in breast cancer.
D001943:Breast Neoplasms / Q000737:chemistry*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D007753:Laboratories / Q000592:standards; D008495:Medical Oncology; D010338:Pathology, Clinical; D017410:Practice Guidelines as Topic; D011786:Quality Control; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*
D018719:Erb-b2 Receptor Tyrosine Kinases